Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Return on Invested Capital (2016 - 2026)

Champions Oncology has reported Return on Invested Capital over the past 16 years, most recently at 0.01% for Q1 2026.

  • For Q1 2026, Return on Invested Capital fell 3.0% year-over-year to 0.01%; the TTM value through Jan 2026 reached 0.01%, down 3.0%, while the annual FY2025 figure was 0.05%, 10.0% up from the prior year.
  • Return on Invested Capital for Q1 2026 was 0.01% at Champions Oncology, down from 0.01% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.1% in Q1 2024 and troughed at 0.1% in Q4 2023.
  • A 5-year average of 0.0% and a median of 0.0% in 2022 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: decreased -10bps in 2023 and later rose 10bps in 2024.
  • Year by year, Return on Invested Capital stood at 0.0% in 2022, then plummeted by -49347bps to 0.1% in 2023, then surged by 56bps to 0.04% in 2024, then soared by 113bps to 0.01% in 2025, then plummeted by -206bps to 0.01% in 2026.
  • Business Quant data shows Return on Invested Capital for CSBR at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.